A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for the Treatment of Fuchs' Corneal Endothelial Dystrophy (FCED)
Source · ClinicalTrials.gov: elamipretide
TLDR
ClinicalTrials.gov lists a Phase 1/2 trial of elamipretide topical ophthalmic solution for Fuchs' Corneal Endothelial Dystrophy as completed. The trial evaluated safety, tolerability, and efficacy in patients with mild to moderate corneal edema; the excerpt provides no results.
- 01The prospective trial was randomized, double-masked, and vehicle-controlled.
- 02The study was conducted in two parts.
- 03Completed status alone does not establish safety or efficacy.
Why it matters Editorial
The listing documents clinical investigation of elamipretide for an eye disorder, but the excerpt does not report outcomes.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
ClinicalTrials.gov: elamipretide
ClinicalTrials.gov: elamipretide
ClinicalTrials.gov: elamipretide
ClinicalTrials.gov: elamipretide